These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 8269617
1. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Cattley RC, Glover SE. Carcinogenesis; 1993 Dec; 14(12):2495-9. PubMed ID: 8269617 [Abstract] [Full Text] [Related]
4. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Marsman DS, Goldsworthy TL, Popp JA. Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604 [Abstract] [Full Text] [Related]
5. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. Hayashi F, Tamura H, Watanabe T, Suga T. Cancer Lett; 1995 May 25; 92(1):87-90. PubMed ID: 7757964 [Abstract] [Full Text] [Related]
6. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y. Jpn J Cancer Res; 1990 Mar 25; 81(3):213-5. PubMed ID: 2112523 [Abstract] [Full Text] [Related]
7. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA. Carcinogenesis; 1989 Mar 25; 10(3):513-9. PubMed ID: 2924396 [Abstract] [Full Text] [Related]
8. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Hayashi F, Tamura H, Yamada J, Kasai H, Suga T. Carcinogenesis; 1994 Oct 25; 15(10):2215-9. PubMed ID: 7955056 [Abstract] [Full Text] [Related]
9. Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Isenberg JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Lington AW, Klaunig JE. Toxicol Sci; 2000 Jul 25; 56(1):73-85. PubMed ID: 10869455 [Abstract] [Full Text] [Related]
10. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Eacho PI, Lanier TL, Brodhecker CA. Carcinogenesis; 1991 Sep 25; 12(9):1557-61. PubMed ID: 1893515 [Abstract] [Full Text] [Related]
11. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Gupta RC, Goel SK, Earley K, Singh B, Reddy JK. Carcinogenesis; 1985 Jun 25; 6(6):933-6. PubMed ID: 4006083 [Abstract] [Full Text] [Related]
12. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators. Anderson SP, Cattley RC, Corton JC. Mol Carcinog; 1999 Dec 25; 26(4):226-38. PubMed ID: 10569800 [Abstract] [Full Text] [Related]
13. Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Seo KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS. Food Chem Toxicol; 2004 Jan 25; 42(1):107-14. PubMed ID: 14630134 [Abstract] [Full Text] [Related]
14. Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)- and phenobarbital-induced hepatocellular changes in rodents. Isenberg JS, Kamendulis LM, Ackley DC, Smith JH, Pugh G, Lington AW, McKee RH, Klaunig JE. Toxicol Sci; 2001 Dec 25; 64(2):192-9. PubMed ID: 11719701 [Abstract] [Full Text] [Related]
15. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate. Watanabe T, Lalwani ND, Reddy JK. Biochem J; 1985 May 01; 227(3):767-75. PubMed ID: 4004798 [Abstract] [Full Text] [Related]
16. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Tomaszewski KE, Agarwal DK, Melnick RL. Carcinogenesis; 1986 Nov 01; 7(11):1871-6. PubMed ID: 3769136 [Abstract] [Full Text] [Related]
17. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Reddy JK, Reddy MK, Usman MI, Lalwani ND, Rao MS. Environ Health Perspect; 1986 Mar 01; 65():317-27. PubMed ID: 3709457 [Abstract] [Full Text] [Related]
18. Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid. Marsman DS, Swanson-Pfeiffer CL, Popp JA. Toxicol Appl Pharmacol; 1993 Sep 01; 122(1):1-6. PubMed ID: 8378924 [Abstract] [Full Text] [Related]
19. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Huber WW, Grasl-Kraupp B, Schulte-Hermann R. Crit Rev Toxicol; 1996 Jun 01; 26(4):365-481. PubMed ID: 8817083 [Abstract] [Full Text] [Related]
20. Lack of induction of hepatic DNA damage on long-term administration of peroxisome proliferators in male F-344 rats. Tamura H, Iida T, Watanabe T, Suga T. Toxicology; 1991 Jun 01; 69(1):55-62. PubMed ID: 1926155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]